Ngm Biopharmaceuticals Inc (NGM) - News Archive

Showing 3 of 3 results.

NGM Bio Announces Successful Completion of Cash Tender Offer, Paving the Way for Transformative Therapeutics

SAN FRANCISCO, April 5, 2024 - NGM Biopharmaceuticals, Inc. (NGM Bio), a pioneering biotechnology company focused on developing innovative therapeutics for patients, made a significant announcement today. The company re...

Apr 5, 2024 • Major Pharmaceutical Preparations Industry Stock Market Announcement

NGM Bio Joins Forces with Affiliates of The Column Group, LP to Redefine Biotechnology

NGM Bio s Merger Agreement: Revolutionizing Biotechnology with The Column GroupSAN FRANCISCO, Feb. 26, 2024 - NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a groundbreaking biotechnology company renowned for its...

Feb 26, 2024 • Major Pharmaceutical Preparations Industry Merger and Acquisition

NGM Bio's Promising Clinical Data for NGM707 and Strategic Focus on Rare Conditions with Unmet Need

NGM Biopharmaceuticals, Inc. (NGM Bio), a prominent biotechnology company dedicated to revolutionizing therapeutic options for patients, recently shared promising clinical findings from an ongoing Phase 1 Part 1b study...

Jan 9, 2024 • Major Pharmaceutical Preparations Industry Clinical Study